GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (TSXV:LXG.H) » Definitions » Interest Coverage

Lexagene Holdings (TSXV:LXG.H) Interest Coverage : 0 (At Loss) (As of Nov. 2022)


View and export this data going back to 2007. Start your Free Trial

What is Lexagene Holdings Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Lexagene Holdings's Operating Income for the three months ended in Nov. 2022 was C$-2.24 Mil. Lexagene Holdings's Interest Expense for the three months ended in Nov. 2022 was C$-0.02 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Lexagene Holdings's Interest Coverage or its related term are showing as below:


TSXV:LXG.H's Interest Coverage is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 18.02
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Lexagene Holdings Interest Coverage Historical Data

The historical data trend for Lexagene Holdings's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Lexagene Holdings Interest Coverage Chart

Lexagene Holdings Annual Data
Trend Mar13 Mar14 Mar15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only No Debt No Debt - - -

Lexagene Holdings Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lexagene Holdings's Interest Coverage

For the Medical Devices subindustry, Lexagene Holdings's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexagene Holdings's Interest Coverage Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Interest Coverage falls into.



Lexagene Holdings Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Lexagene Holdings's Interest Coverage for the fiscal year that ended in Feb. 2022 is calculated as

Here, for the fiscal year that ended in Feb. 2022, Lexagene Holdings's Interest Expense was C$-0.09 Mil. Its Operating Income was C$-13.43 Mil. And its Long-Term Debt & Capital Lease Obligation was C$1.14 Mil.

Lexagene Holdings did not have earnings to cover the interest expense.

Lexagene Holdings's Interest Coverage for the quarter that ended in Nov. 2022 is calculated as

Here, for the three months ended in Nov. 2022, Lexagene Holdings's Interest Expense was C$-0.02 Mil. Its Operating Income was C$-2.24 Mil. And its Long-Term Debt & Capital Lease Obligation was C$0.76 Mil.

Lexagene Holdings did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Lexagene Holdings  (TSXV:LXG.H) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Lexagene Holdings Interest Coverage Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexagene Holdings (TSXV:LXG.H) Business Description

Traded in Other Exchanges
N/A
Address
500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Lexagene Holdings (TSXV:LXG.H) Headlines

No Headlines